Bolt Bio preps clinical trials of immune-stimulating cancer drug in stubborn solid tumors

Bolt Bio preps clinical trials of immune-stimulating cancer drug in stubborn solid tumors

AtriCure Enters Into Definitive Agreement to Acquire SentreHEART

AtriCure Enters Into Definitive Agreement to Acquire SentreHEART

Menlo Therapeutics’ Successful Phase 2 Clinical Trial of Serlopitant Demonstrates Reduction of Pruritus Associated with Psoriasis

Menlo Therapeutics’ Successful Phase 2 Clinical Trial of Serlopitant Demonstrates Reduction of Pruritus Associated with Psoriasis

Biohaven Delivers Positive Phase 3 Results with Rimegepant Zydis® Orally Dissolving Tablet (ODT): Rapid and Lasting Benefit for the Acute Treatment of Migraine

Biohaven Delivers Positive Phase 3 Results with Rimegepant Zydis® Orally Dissolving Tablet (ODT): Rapid and Lasting Benefit for the Acute Treatment of Migraine

Crinetics Pharmaceuticals Announces Pricing of Initial Public Offering

Crinetics Pharmaceuticals Announces Pricing of Initial Public Offering

Tricida Announces Pricing of Initial Public Offering

Tricida Announces Pricing of Initial Public Offering